Glenn John's Form 4 filing
Iradimed Corp (IRMD) · filed Dec 12, 2025
- Accession no.
- 0001253497-25-000015
- Filed
- Dec 12, 2025
- Trade date
- Dec 11, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.46M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Glenn JohnCIK 0001253497 | Officer (CHIEF FINANCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | Common Stock | SSaleDisposed | −14,468 | $97.26F1 | −$1,407,157.68 | 7,894 | Direct | |
| Dec 11, 2025 | Common Stock | SSaleDisposed | −532 | $98.09 | −$52,183.88 | 7,362 | Direct | |
| Dec 11, 2025 | Common Stock | MOption exerciseAcquired | +1,812 | –F2 | – | 9,174 | Direct | |
| Dec 11, 2025 | Common Stock | FTax withholdingDisposed | −714 | $97.38 | −$69,529.32 | 8,460 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | Common Stock | MOption exerciseDisposed | −1,812 | $0.00 | $0 | 3,624 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades at prices ranging from $97.00 to $97.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F2
Restricted stock units convert into common stock on a one-for-one basis.
Referenced by the price of 1 transaction in Table I.